BMO Capital Markets Initiates Coverage on Omada Health (NASDAQ:OMDA)

Stock analysts at BMO Capital Markets initiated coverage on shares of Omada Health (NASDAQ:OMDA) in a research note issued to investors on Thursday, MarketBeat.com reports. The firm set an “outperform” rating and a $27.00 price target on the stock. BMO Capital Markets’ price objective suggests a potential upside of 34.66% from the stock’s current price.

OMDA has been the subject of a number of other reports. Canaccord Genuity Group lifted their price target on Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Barclays lifted their target price on Omada Health from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Robert W. Baird started coverage on Omada Health in a research report on Friday, September 5th. They set a “neutral” rating and a $24.00 price target on the stock. Evercore ISI lifted their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Finally, Baird R W upgraded shares of Omada Health to a “hold” rating in a research note on Friday, September 5th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $26.33.

Omada Health Stock Performance

OMDA opened at $20.05 on Thursday. Omada Health has a 12-month low of $14.14 and a 12-month high of $28.40. The company has a fifty day moving average of $23.40.

Hedge Funds Weigh In On Omada Health

Several institutional investors have recently modified their holdings of OMDA. Raymond James Financial Inc. acquired a new position in Omada Health during the 2nd quarter valued at about $32,000. Strs Ohio acquired a new position in shares of Omada Health during the third quarter worth approximately $38,000. Rakuten Investment Management Inc. bought a new stake in Omada Health during the 3rd quarter valued at $49,000. JPMorgan Chase & Co. acquired a new position in Omada Health during the 3rd quarter worth $82,000. Finally, Rhumbline Advisers bought a new position in shares of Omada Health in the third quarter worth $176,000.

About Omada Health

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.